ImmunoGen (IMGN) Stock Forecast for 2025, 2026, 2027. Sell or Buy Prediction







Top 5 Coins for the Maximum Passive Income from Staking by 2024

February 5, 2025 Top 5 Coins for the Maximum Passive Income from Staking by 2024

Staking is one of the ways that is now being used as a secure and profitable way to earn money without doing anything…
Trading Stocks With AI: A Modern Approach

January 21, 2025 Trading Stocks With AI: A Modern Approach

The stock market can feel overwhelming, especially with its constant ups and downs. Trading stocks with AI is revolutionizing how investors analyze trends,…
Bitcoin Is Great, but Here Are 3 Altcoins Worth Considering in 2025

January 21, 2025 Bitcoin Is Great, but Here Are 3 Altcoins Worth Considering in 2025

The launch of spot Bitcoin (CRYPTO: BTC) exchange-traded funds (ETFs) in January 2025 marked a turning point in the cryptocurrency market. These ETFs…
Advanced Charting Tools For Traders

January 1, 2025 Advanced Charting Tools For Traders

Ever tried deciphering market trends with the intensity of a detective peering over cryptic clues? Enter the realm of Advanced Charting, where complex…
Why Is Trading Important?

December 21, 2024 Why Is Trading Important?

Trade isn’t just figures on a spreadsheet; it’s the pulse of our global community. In 2018, the United States faced a staggering $621…

ImmunoGen (IMGN) Stock Forecast for 2025, 2026, 2027. Sell or Buy?

Updated: February 10, 2025 (18:18)

Sector: Healthcare

The share price of ImmunoGen, Inc. (IMGN) now

This company is DELISTED
Latest session on the 26th of February for
ImmunoGen, Inc. is negative
Trading Volume: 40
Open: 31.23 /  High: 31.23 /  Low: 31.23
Current value: $31.23

Are you interested in ImmunoGen, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the ImmunoGen stock price in 2025, 2026, 2027. How much will one ImmunoGen share be worth in 2025 - 2027?

When should I take profit in ImmunoGen stock? When should I record a loss on ImmunoGen stock? What are analysts' forecasts for ImmunoGen stock? What is the future of ImmunoGen stock? We forecast ImmunoGen stock performance using neural networks based on historical data on ImmunoGen stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

ImmunoGen stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2025, 2026, 2027, and ) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for ImmunoGen shares. This happens once a day.


Historical and forecast chart of ImmunoGen stock

The chart below shows the historical price of ImmunoGen stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the ImmunoGen stock price can be found in the table below.

No data

Long-term forecasts by years.

ImmunoGen, Inc., a clinical-stage biotechnology company, is developing antibody-drug conjugate (ADC) therapies for cancer. Its candidate products include mirvetuximab soravtansine, an alpha-folate receptor-targeted ADC that is in phase III clinical trials for the treatment of platinum-resistant ovarian cancer; and IMGN632, an ADC targeting CD123, which is in phase I clinical trials for the treatment of AML and blast plasmacytoid dendritic cell neoplasms.

Trending Themes in the Healthcare Sector

ImmunoGen daily forecast for a month

Date Target Pes. Opt. Vol., %
Feb 12 31.44 31.22 31.51 0.94
Feb 13 31.29 31.17 31.49 1.01
Feb 14 31.35 31.19 31.47 0.89
Feb 15 31.06 30.98 31.27 0.93
Feb 16 31.08 31.00 31.31 1.01
Feb 17 30.98 30.77 31.22 1.47
Feb 18 30.93 30.74 31.04 0.98
Feb 19 31.01 30.85 31.20 1.15
Feb 20 30.75 30.64 30.91 0.87
Feb 21 30.65 30.53 30.89 1.16
Feb 22 30.71 30.49 30.86 1.21
Feb 23 30.76 30.61 30.90 0.96
Feb 24 30.83 30.59 30.90 1.01
Feb 25 30.92 30.80 31.09 0.95
Feb 26 31.11 30.87 31.18 1.02
Feb 27 31.02 30.79 31.17 1.23
Feb 28 31.12 30.97 31.20 0.73
Mar 01 31.34 31.26 31.42 0.51
Mar 02 31.33 31.16 31.48 1.03
Mar 03 31.24 31.04 31.40 1.16
Mar 04 31.26 31.15 31.36 0.67
Mar 05 30.95 30.86 31.18 1.05
Mar 06 31.19 31.01 31.33 1.04
Mar 07 31.14 31.03 31.33 0.96
Mar 08 31.24 31.04 31.34 0.98
Mar 09 31.52 31.32 31.74 1.32
Mar 10 31.51 31.42 31.67 0.82
Mar 11 31.52 31.33 31.59 0.81
Mar 12 31.29 31.22 31.38 0.52
Mar 13 30.98 30.76 31.16 1.30

ImmunoGen Daily Price Targets


ImmunoGen Stock Forecast 02-12-2025.

Forecast target price for 02-12-2025: $31.44.
Positive dynamics for ImmunoGen shares will prevail with possible volatility of 0.928%.
Pessimistic target level: 31.22
Optimistic target level: 31.51

ImmunoGen Stock Forecast 02-13-2025.

Forecast target price for 02-13-2025: $31.29.
Negative dynamics for ImmunoGen shares will prevail with possible volatility of 1.004%.
Pessimistic target level: 31.17
Optimistic target level: 31.49

ImmunoGen Stock Forecast 02-14-2025.

Forecast target price for 02-14-2025: $31.35.
Positive dynamics for ImmunoGen shares will prevail with possible volatility of 0.887%.
Pessimistic target level: 31.19
Optimistic target level: 31.47

ImmunoGen Stock Forecast 02-15-2025.

Forecast target price for 02-15-2025: $31.06.
Negative dynamics for ImmunoGen shares will prevail with possible volatility of 0.924%.
Pessimistic target level: 30.98
Optimistic target level: 31.27

ImmunoGen Stock Forecast 02-16-2025.

Forecast target price for 02-16-2025: $31.08.
Positive dynamics for ImmunoGen shares will prevail with possible volatility of 1.002%.
Pessimistic target level: 31.00
Optimistic target level: 31.31

ImmunoGen Stock Forecast 02-17-2025.

Forecast target price for 02-17-2025: $30.98.
Negative dynamics for ImmunoGen shares will prevail with possible volatility of 1.449%.
Pessimistic target level: 30.77
Optimistic target level: 31.22

IMGN (IMGN) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Mar. 33.37 22.91 47.25 51.52
Apr. 41.73 25.80 46.49 44.52
May. 34.36 23.39 42.78 45.32
Jun. 19.67 13.84 26.73 48.23
Jul. 12.61 7.36 15.55 52.67
Aug. 18.57 12.54 23.76 47.23
Sep. 23.97 16.73 28.62 41.54
Oct. 26.57 20.51 33.08 38.00
Nov. 24.60 18.01 32.45 44.50
Dec. 35.11 27.51 48.12 42.84

ImmunoGen forecast for this year


ImmunoGen Stock Prediction for Mar 2025

An uptrend is forecast for this month with an optimal target price of $33.3661. Pessimistic: $22.91. Optimistic: $47.25


ImmunoGen Stock Prediction for Apr 2025

An uptrend is forecast for this month with an optimal target price of $41.7344. Pessimistic: $25.80. Optimistic: $46.49


ImmunoGen Stock Prediction for May 2025

An downtrend is forecast for this month with an optimal target price of $34.3599. Pessimistic: $23.39. Optimistic: $42.78


ImmunoGen Stock Prediction for Jun 2025

An downtrend is forecast for this month with an optimal target price of $19.671. Pessimistic: $13.84. Optimistic: $26.73


ImmunoGen Stock Prediction for Jul 2025

An downtrend is forecast for this month with an optimal target price of $12.6072. Pessimistic: $7.36. Optimistic: $15.55


ImmunoGen Stock Prediction for Aug 2025

An uptrend is forecast for this month with an optimal target price of $18.5716. Pessimistic: $12.54. Optimistic: $23.76


ImmunoGen Stock Prediction for Sep 2025

An uptrend is forecast for this month with an optimal target price of $23.9704. Pessimistic: $16.73. Optimistic: $28.62


ImmunoGen Stock Prediction for Oct 2025

An uptrend is forecast for this month with an optimal target price of $26.5664. Pessimistic: $20.51. Optimistic: $33.08


ImmunoGen Stock Prediction for Nov 2025

An downtrend is forecast for this month with an optimal target price of $24.5978. Pessimistic: $18.01. Optimistic: $32.45


ImmunoGen Stock Prediction for Dec 2025

An uptrend is forecast for this month with an optimal target price of $35.1134. Pessimistic: $27.51. Optimistic: $48.12



ImmunoGen (IMGN) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 26.31 15.66 30.51 48.66
Feb 28.26 16.02 31.80 49.64
Mar 38.40 24.17 44.09 45.18
Apr 27.90 24.24 34.42 29.57
May 33.78 27.04 46.49 41.83
Jun 52.84 45.01 73.02 38.36
Jul 48.93 28.85 62.59 53.91
Aug 53.39 42.43 61.00 30.43
Sep 57.34 48.52 76.63 36.68
Oct 72.71 46.60 98.40 52.65
Nov 76.44 58.57 106.06 44.78
Dec 85.58 70.46 95.83 26.47

ImmunoGen (IMGN) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 77.29 46.89 90.07 47.94
Feb 104.61 56.91 133.23 57.29
Mar 85.53 58.23 120.14 51.53
Apr 92.35 63.93 118.67 46.13
May 116.04 96.20 142.50 32.49
Jun 137.87 82.07 196.81 58.30
Jul 158.30 129.43 204.32 36.65
Aug 155.59 105.93 199.05 46.78
Sep 100.61 55.30 139.03 60.22
Oct 100.61 85.70 116.09 26.18
Nov 92.58 69.36 122.66 43.45
Dec 88.36 57.63 111.52 48.32

ImmunoGen information and performance

ImmunoGen Address

N/A

Market Capitalization: N/A $

Market capitalization of the ImmunoGen, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of IMGN shares in the company outstanding by the market price of one share.

EBITDA: N/A $

EBITDA of ImmunoGen is earnings before interest, income tax and depreciation of assets.

PE Ratio: N/A

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: N/A

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: N/A

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: N/A
Trailing PE: N/A

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: N/A

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: N/A

Enterprise Value (EV) /Revenue

EV To EBITDA: N/A

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: N/A

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A

FAQ (Frequently Asked Questions about ImmunoGen Stock)

Should I Buy ImmunoGen Shares in 2025 year?

The maximum forecasted share price for next year is $85.58, which is $54.35 higher than the current stock price. By investing in ImmunoGen shares today for a one-year period, you could achieve a profit of 174.05%. With an investment horizon of up to two years, the target share price is $158.30. resulting in a profit of 406.88% ($127.07 per share).

Does ImmunoGen pay dividends?

No, it does not

Which economic sector do ImmunoGen's shares belong to?

ImmunoGen's shares belong to the "Healthcare" sector of economic.

Which other securities belong to the same sector as ImmunoGen's shares?

You can view all the stocks that are part of the same sector as ImmunoGen's shares in the Healthcare section.


Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.